Rice U. expert: Key is creating ML systems that question their own predictions
Rice University statistician Genevera Allen says scientists must keep questioning the accuracy and reproducibility of scientific discoveries made by machine-learning techniques until researchers develop new computational systems that can critique themselves.
Allen, associate professor of statistics, computer science and electrical and computer engineering at Rice and of pediatrics-neurology at Baylor College of Medicine, will address the topic in both a press briefing and a general session today at the 2019 Annual Meeting of the American Association for the Advancement of Science (AAAS).
“The question is, ‘Can we really trust the discoveries that are currently being made using machine-learning techniques applied to large data sets?’” Allen said. “The answer in many situations is probably, ‘Not without checking,’ but work is underway on next-generation machine-learning systems that will assess the uncertainty and reproducibility of their predictions.”
Machine learning (ML) is a branch of statistics and computer science concerned with building computational systems that learn from data rather than following explicit instructions. Allen said much attention in the ML field has focused on developing predictive models that allow ML to make predictions about future data based on its understanding of data it has studied.
“A lot of these techniques are designed to always make a prediction,” she said. “They never come back with ‘I don’t know,’ or ‘I didn’t discover anything,’ because they aren’t made to.”
She said uncorroborated data-driven discoveries from recently published ML studies of cancer data are a good example.
“In precision medicine, it’s important to find groups of patients that have genomically similar profiles so you can develop drug therapies that are targeted to the specific genome for their disease,” Allen said. “People have applied machine learning to genomic data from clinical cohorts to find groups, or clusters, of patients with similar genomic profiles.
“But there are cases where discoveries aren’t reproducible; the clusters discovered in one study are completely different than the clusters found in another,” she said. “Why? Because most machine-learning techniques today always say, ‘I found a group.’ Sometimes, it would be far more useful if they said, ‘I think some of these are really grouped together, but I’m uncertain about these others.’”
The Latest on: Machine-learning discoveries
via Google News
The Latest on: Machine-learning discoveries
- A Bayesian machine learning approach for drug target identification using diverse data typeson November 19, 2019 at 2:35 am
This unexpected discovery on the DRD2 being a direct-binding target for ONC201 ... such as the readily interpretable nature of a likelihood ratio compared to other more complicated machine learning ...
- How to Use Machine Learning to Drive Real Valueon November 18, 2019 at 7:44 pm
The truth is, the real value of machine learning is that it allows businesses to try new things, amplify creative strengths, reveal new discoveries and enable collaboration across the organization.
- Neural architecture search automates the development of deep learning-based models for cancer researchon November 18, 2019 at 12:58 pm
That we can train it faster means that we can build models faster; this, in turn, means that we can push the drug-discovery pipeline faster." Indeed, NAS will soon begin to produce impacts in the ...
- Google details DeepMind AI’s role in Play Store app recommendationson November 18, 2019 at 12:54 pm
AI and machine learning model architectures developed by Alphabet’s DeepMind have substantially improved the Google Play Store’s discovery systems, according to Google. In a blog post this morning, ...
- Lenovo and Intel team up for Harvard Supercomputer and New Exascale Visionary Councilon November 18, 2019 at 9:24 am
The additional cores and enhanced performance of the system are also attracting researchers from additional departments at the university, such as Psychology and the School of Public Health, to more ...
- GlaxoSmith Kline (GSK): Seeking AI and ML experts for data-driven drug discovery and developmenton November 14, 2019 at 12:03 pm
GlaxoSmithKline (GSK) is creating a data-focused culture and a global machine-learning team. GlaxoSmithKline’s (GSK’s) data-first approach to drug discovery and development comes directly from chief ...
- Reliable and explainable machine-learning methods for accelerated material discoveryon November 14, 2019 at 3:00 am
Second, to overcome these challenges, we propose a general-purpose explainable and reliable machine-learning framework. Specifically, we propose a generic pipeline that employs an ensemble of simpler ...
- Machine Learning for Shovel Tooth Failure Detectionon November 13, 2019 at 7:59 am
Due to the relative infrequency of broken shovel teeth, the false discovery rate (FDR) may be greater than 99%.here are several ... deployable implementation of this methodology. New combinations of ...
- Lantern Phrama Selects REPROCELL Inc., for Drug Screening and Biomarker Discovery Serviceson November 11, 2019 at 9:52 pm
Lantern Pharma a clinical stage oncology biotech leveraging A.I. and machine learning genomics company has selected REPROCELL Inc. to provide drug screening and drug sensitivity services. BELTSVILLE, ...
- Lifebit Launches Federated Genomics Cloud Operating System for Accelerated Discoveryon November 7, 2019 at 8:22 am
As a fully federated, cloud-native system, Lifebit CloudOS is designed to accelerate discoveries for companies in the pharmaceutical ... It works as a managed service of one’s cloud or HPC, ensuring ...
via Bing News